Second_RB
messenger_NN
up-regulation_NN
of_IN
androgen_NN
receptor_NN
gene_NN
transcription_NN
is_VBZ
absent_JJ
in_IN
androgen_NN
insensitive_JJ
human_JJ
prostatic_JJ
carcinoma_NN
cell_NN
lines_NNS
,_,
PC-3_NN
and_CC
DU-145_NN
._.

A_DT
theoretical_JJ
pathway_NN
of_IN
transcriptional_JJ
regulation_NN
of_IN
the_DT
androgen_NN
receptor_NN
-LRB-_-LRB-
AR_NN
-RRB-_-RRB-
gene_NN
is_VBZ
via_IN
a_DT
cAMP_NN
response_NN
element_NN
-LRB-_-LRB-
CRE_NN
-RRB-_-RRB-
present_JJ
in_IN
its_PRP$
promoter_NN
region_NN
-LRB-_-LRB-
-508_CD
to_TO
-501_CD
-RRB-_-RRB-
._.

After_IN
20_CD
h_NN
of_IN
stimulation_NN
with_IN
8-bromo-cAMP_NN
,_,
AR_NN
mRNA_NN
was_VBD
upregulated_VBN
in_IN
LNCaP_NN
but_CC
not_RB
in_IN
either_CC
PC-3_NN
or_CC
DU-145_NN
cell_NN
lines_NNS
._.

We_PRP
have_VBP
demonstrated_VBN
that_IN
the_DT
level_NN
of_IN
CRE_NN
binding_NN
protein_NN
-LRB-_-LRB-
CREB_NN
-RRB-_-RRB-
was_VBD
the_DT
same_JJ
in_IN
all_DT
cell_NN
lines_NNS
and_CC
that_IN
the_DT
putative_JJ
AR-CRE_NN
forms_VBZ
specific_JJ
and_CC
compatible_JJ
protein_NN
interactions_NNS
with_IN
CREB_NN
._.

The_DT
ability_NN
to_TO
regulate_VB
AR_NN
gene_NN
transcription_NN
via_IN
the_DT
second_JJ
messenger_NN
pathway_NN
is_VBZ
lost_VBN
in_IN
the_DT
PC-3_NN
and_CC
DU-145_NN
cell_NN
lines_NNS
._.

This_DT
may_MD
be_VB
an_DT
important_JJ
primary_JJ
mechanism_NN
of_IN
androgen_NN
insensitivity_NN
in_IN
prostate_NN
cancer_NN
._.

